Since 1923, we have been focused on innovation and leadership in diabetes care. Today we have a broad portfolio of medicines.
Since the launch of our first pen needle in 1985, we have been committed to enhancing injection experience by putting technology in patient hands.
Access information on our products for rare bleeding disorders, growth hormone-related disorders, and women's health.
Find information on our treatment for chronic weight management in adults who are overweight with one weight-related comorbidity or obesity.
The link above used in conjunction with the FDA-approved product labeling may be used to determine U.S. patents associated with the corresponding U.S. marketed product.
A place to find different points of view
from inside Novo Nordisk and the communities we serve.
A Novo Nordisk employee shares her family’s story of fostering more than 100 kids and finding their adopted son.
A mother takes on diabetes and cancer with her son by her side.
We’ve partnered with local farms and programs for a healthier Mississippi.
People in Houston find diabetes support where they worship.
Read more about this Cities Changing Diabetes initiative
A teen shares her story of living with diabetes and a message for others.
We celebrate 11 consecutive years on the list.
Ashley and Daniel both have type 1 diabetes. They found love and understanding in each other.
We have information for furloughed workers and others who need help affording our medicines.
Novo Nordisk Obesity Patient Ambassadors cover the largest obesity conference in the world.
For more than half of the 30 years I’ve lived with type 1 diabetes, I depended on human insulin to effectively control my blood sugars.